These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 11506127)
1. Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Minoda Y; Kharasch ED Anesthesiology; 2001 Aug; 95(2):509-14. PubMed ID: 11506127 [TBL] [Abstract][Full Text] [Related]
2. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4. Spracklin DK; Thummel KE; Kharasch ED Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607 [TBL] [Abstract][Full Text] [Related]
3. Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4. Kharasch ED; Hankins DC; Fenstamaker K; Cox K Eur J Clin Pharmacol; 2000; 55(11-12):853-9. PubMed ID: 10805064 [TBL] [Abstract][Full Text] [Related]
4. Roles of human CYP2A6 and rat CYP2B1 in the oxidation of (+)-fenchol by liver microsomes. Miyazawa M; Gyoubu K Xenobiotica; 2007 Sep; 37(9):943-53. PubMed ID: 17992728 [TBL] [Abstract][Full Text] [Related]
5. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Nakajima M; Yamamoto T; Nunoya K; Yokoi T; Nagashima K; Inoue K; Funae Y; Shimada N; Kamataki T; Kuroiwa Y Drug Metab Dispos; 1996 Nov; 24(11):1212-7. PubMed ID: 8937855 [TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 species involved in the metabolism of quinoline. Reigh G; McMahon H; Ishizaki M; Ohara T; Shimane K; Esumi Y; Green C; Tyson C; Ninomiya S Carcinogenesis; 1996 Sep; 17(9):1989-96. PubMed ID: 8824525 [TBL] [Abstract][Full Text] [Related]
7. Human halothane reduction in vitro by cytochrome P450 2A6 and 3A4: identification of low and high KM isoforms. Spracklin DK; Kharasch ED Drug Metab Dispos; 1998 Jun; 26(6):605-7. PubMed ID: 9616199 [No Abstract] [Full Text] [Related]
8. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin. Heyn H; White RB; Stevens JC Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603 [TBL] [Abstract][Full Text] [Related]
9. In vitro metabolism of (-)-camphor using human liver microsomes and CYP2A6. Gyoubu K; Miyazawa M Biol Pharm Bull; 2007 Feb; 30(2):230-3. PubMed ID: 17268056 [TBL] [Abstract][Full Text] [Related]
10. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Pearce R; Greenway D; Parkinson A Arch Biochem Biophys; 1992 Oct; 298(1):211-25. PubMed ID: 1381906 [TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Taavitsainen P; Juvonen R; Pelkonen O Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487 [TBL] [Abstract][Full Text] [Related]
12. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers. Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148 [TBL] [Abstract][Full Text] [Related]
13. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450. Ghosal A; Satoh H; Thomas PE; Bush E; Moore D Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602 [TBL] [Abstract][Full Text] [Related]
14. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes. Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639 [TBL] [Abstract][Full Text] [Related]
15. Isoflurane acts as an inhibitor of oxidative dehalogenation while acting as an accelerator of reductive dehalogenation of halothane in guinea pig liver microsomes. Fujii K Toxicology; 1995 Dec; 104(1-3):123-8. PubMed ID: 8560490 [TBL] [Abstract][Full Text] [Related]
16. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of (+)-terpinen-4-ol by cytochrome P450 enzymes in human liver microsomes. Haigou R; Miyazawa M J Oleo Sci; 2012; 61(1):35-43. PubMed ID: 22188805 [TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA. Jacobson PA; Green K; Birnbaum A; Remmel RP Cancer Chemother Pharmacol; 2002 Jun; 49(6):461-7. PubMed ID: 12107550 [TBL] [Abstract][Full Text] [Related]
19. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes. Zhang Y; Guo X; Lin ET; Benet LZ Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Draper AJ; Madan A; Parkinson A Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]